Cargando…

Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design

BACKGROUND AND AIMS: Liver fibrosis leading to chronic liver disease (CLD) is a major cause of morbidity, mortality and health‐care expenditure worldwide. The “gold standard” for diagnosis and staging of liver fibrosis is histological analysis of liver tissue obtained by liver biopsy, an invasive pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzudzor, Bartholomew, Hammond, Harris, Tachi, Kenneth, Alisi, Anna, Vento, Sandro, Gyasi, Richard Kwasi, Aheto, Justice Moses K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919473/
https://www.ncbi.nlm.nih.gov/pubmed/36789398
http://dx.doi.org/10.1002/hsr2.1101
_version_ 1784886833685987328
author Dzudzor, Bartholomew
Hammond, Harris
Tachi, Kenneth
Alisi, Anna
Vento, Sandro
Gyasi, Richard Kwasi
Aheto, Justice Moses K
author_facet Dzudzor, Bartholomew
Hammond, Harris
Tachi, Kenneth
Alisi, Anna
Vento, Sandro
Gyasi, Richard Kwasi
Aheto, Justice Moses K
author_sort Dzudzor, Bartholomew
collection PubMed
description BACKGROUND AND AIMS: Liver fibrosis leading to chronic liver disease (CLD) is a major cause of morbidity, mortality and health‐care expenditure worldwide. The “gold standard” for diagnosis and staging of liver fibrosis is histological analysis of liver tissue obtained by liver biopsy, an invasive procedure. Therefore, there is the need to identify noninvasive and inexpensive markers for diagnosis and staging of liver fibrosis. This study aimed at evaluating the correlation of hyaluronic acid (HA) and 25‐hydroxyvitamin D (25‐OH vitamin D) serum levels as markers of fibrosis with histologically staged and graded liver biopsies obtained from CLD patients. METHODS: This was a case‐control study involving 40 CLD patients requiring liver biopsies and 40 controls. Liver biopsies were staged to determine the degree of fibrosis. Serum levels of 25‐OH vitamin D and HA were determined using ELISA. Statistical analyses were performed to determine differences in HA and 25‐OH vitamin D levels between controls and patients as well as to correlate the biomarkers with the stages of fibrosis. RESULTS: CLD patients showed significant (p < 0.001) increase in the levels of AST, ALT, GGT, compared to the controls. Patients also had significantly (p < 0.001) lower serum 25‐OH vitamin D and higher HA (p < 0.001) levels compared to the controls. Additionally, 25‐OH vitamin D levels of the CLD patients were significantly different across the stages of liver fibrosis likewise serum HA levels. Furthermore, 25‐OH vitamin D levels inversely correlated with the severity of liver fibrosis. A significant negative correlation (r = −0.33, p < 0.05) between CLD patients' HA and 25‐OH vitamin D were found. CONCLUSION: CLD patients had significantly reduced serum 25‐OH vitamin D and higher HA. Both markers correlated with the degree of liver fibrosis. These findings have major clinical translatable implication in the use of vitamin D supplementation in the management of CLD in Ghana.
format Online
Article
Text
id pubmed-9919473
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99194732023-02-13 Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design Dzudzor, Bartholomew Hammond, Harris Tachi, Kenneth Alisi, Anna Vento, Sandro Gyasi, Richard Kwasi Aheto, Justice Moses K Health Sci Rep Original Research BACKGROUND AND AIMS: Liver fibrosis leading to chronic liver disease (CLD) is a major cause of morbidity, mortality and health‐care expenditure worldwide. The “gold standard” for diagnosis and staging of liver fibrosis is histological analysis of liver tissue obtained by liver biopsy, an invasive procedure. Therefore, there is the need to identify noninvasive and inexpensive markers for diagnosis and staging of liver fibrosis. This study aimed at evaluating the correlation of hyaluronic acid (HA) and 25‐hydroxyvitamin D (25‐OH vitamin D) serum levels as markers of fibrosis with histologically staged and graded liver biopsies obtained from CLD patients. METHODS: This was a case‐control study involving 40 CLD patients requiring liver biopsies and 40 controls. Liver biopsies were staged to determine the degree of fibrosis. Serum levels of 25‐OH vitamin D and HA were determined using ELISA. Statistical analyses were performed to determine differences in HA and 25‐OH vitamin D levels between controls and patients as well as to correlate the biomarkers with the stages of fibrosis. RESULTS: CLD patients showed significant (p < 0.001) increase in the levels of AST, ALT, GGT, compared to the controls. Patients also had significantly (p < 0.001) lower serum 25‐OH vitamin D and higher HA (p < 0.001) levels compared to the controls. Additionally, 25‐OH vitamin D levels of the CLD patients were significantly different across the stages of liver fibrosis likewise serum HA levels. Furthermore, 25‐OH vitamin D levels inversely correlated with the severity of liver fibrosis. A significant negative correlation (r = −0.33, p < 0.05) between CLD patients' HA and 25‐OH vitamin D were found. CONCLUSION: CLD patients had significantly reduced serum 25‐OH vitamin D and higher HA. Both markers correlated with the degree of liver fibrosis. These findings have major clinical translatable implication in the use of vitamin D supplementation in the management of CLD in Ghana. John Wiley and Sons Inc. 2023-02-11 /pmc/articles/PMC9919473/ /pubmed/36789398 http://dx.doi.org/10.1002/hsr2.1101 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Dzudzor, Bartholomew
Hammond, Harris
Tachi, Kenneth
Alisi, Anna
Vento, Sandro
Gyasi, Richard Kwasi
Aheto, Justice Moses K
Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design
title Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design
title_full Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design
title_fullStr Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design
title_full_unstemmed Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design
title_short Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design
title_sort serum 25‐hydroxyvitamin d and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in ghana: a case‐control study design
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919473/
https://www.ncbi.nlm.nih.gov/pubmed/36789398
http://dx.doi.org/10.1002/hsr2.1101
work_keys_str_mv AT dzudzorbartholomew serum25hydroxyvitamindandhyaluronicacidlevelsasmarkersoffibrosisinpatientswithchronicliverdiseaseatthemaintertiaryreferralhospitalinghanaacasecontrolstudydesign
AT hammondharris serum25hydroxyvitamindandhyaluronicacidlevelsasmarkersoffibrosisinpatientswithchronicliverdiseaseatthemaintertiaryreferralhospitalinghanaacasecontrolstudydesign
AT tachikenneth serum25hydroxyvitamindandhyaluronicacidlevelsasmarkersoffibrosisinpatientswithchronicliverdiseaseatthemaintertiaryreferralhospitalinghanaacasecontrolstudydesign
AT alisianna serum25hydroxyvitamindandhyaluronicacidlevelsasmarkersoffibrosisinpatientswithchronicliverdiseaseatthemaintertiaryreferralhospitalinghanaacasecontrolstudydesign
AT ventosandro serum25hydroxyvitamindandhyaluronicacidlevelsasmarkersoffibrosisinpatientswithchronicliverdiseaseatthemaintertiaryreferralhospitalinghanaacasecontrolstudydesign
AT gyasirichardkwasi serum25hydroxyvitamindandhyaluronicacidlevelsasmarkersoffibrosisinpatientswithchronicliverdiseaseatthemaintertiaryreferralhospitalinghanaacasecontrolstudydesign
AT ahetojusticemosesk serum25hydroxyvitamindandhyaluronicacidlevelsasmarkersoffibrosisinpatientswithchronicliverdiseaseatthemaintertiaryreferralhospitalinghanaacasecontrolstudydesign